key: cord-0966563-3dp3u7pp
authors: Patil, Neha R.; Herc, Erica S.; Girgis, Marian
title: Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection
date: 2020-07-06
journal: Hematol Oncol Stem Cell Ther
DOI: 10.1016/j.hemonc.2020.06.005
sha: 83a1a7a1f136e8c43ac7b4704cddb86d93668623
doc_id: 966563
cord_uid: 3dp3u7pp

BACKGROUND: Lymphopenia, thrombocytopenia, and elevated D-dimer and ferritin levels are frequently reported in patients with severe coronavirus disease 2019 (COVID-19). Here we report a case of cold agglutinin disease (CAD), autoimmune hemolytic anemia (AIHA), and pulmonary embolism as a presentation of COVID-19 infection. CASE REPORT: A 51-year-old African–American woman presented to the emergency room with fever and shortness of breath. She was tachycardic, febrile, and had an oxygen saturation of 88% on room air. Laboratory studies showed hemoglobin (Hb) 5.1 g/dL, D-dimer 4.55 µg/mL, and C-reactive protein 12.3 mg/dL. Computed tomography scan of the chest showed acute pulmonary embolism involving the bilateral lower lobe segmental branches. Her influenza test was negative, but her SARS-CoV-2 test returned positive. Due to severe anemia, she was not started on any anticoagulation. Haptoglobin was low. Direct antiglobulin test returned positive for anticomplement and negative for anti-immunoglobulin G. Cold agglutinin titer was 80. Mycoplasma, Epstein–Barr virus, parvovirus, human immunodeficiency viruses, and acute hepatitis screen were negative. Abdominal and pelvic computed tomography showed a normal liver and spleen without lymphadenopathy. Peripheral blood smear showed red blood cell agglutination. On Day 2, she became hypoxic requiring 6 L oxygen. Since her Hb remained stable, she was started on low-intensity unfractionated heparin. Inflammatory markers subsequently improved and she was weaned off oxygen. Her Hb remained stable at 9 g/dL and she was discharged home. After 2 weeks, her Hb increased to 11 g/dL. CONCLUSION: As exemplified in this case report, COVID-19 infection can lead to thromboembolism, CAD, and AIHA and it should be recognized as a potential etiology to such rare diseases.

Case report: A 51-year-old African-American woman presented to the emergency room with 32 fever and shortness of breath. She was tachycardic, febrile, and had an oxygen saturation of 33 88% on room air. Laboratory studies showed hemoglobin (Hb) 5.1 g/dL, D-dimer 4.55 µg/mL, 34 and C-reactive protein 12.3 mg/dL. Computed tomography scan of the chest showed acute pul-35 monary embolism involving the bilateral lower lobe segmental branches. Her influenza test was 36 negative, but her SARS-CoV-2 test returned positive. Due to severe anemia, she was not started 37 on any anticoagulation. Haptoglobin [1] [2] [3] . Disseminated intravascular coagulation [4] and 63 venous thromboembolism (VTE) [5] have also been 64 reported. 65 We report a case of cold agglutinin disease (CAD), There was also concern for breast surgical site infection 

Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection

Primary chronic cold agglutinin disease: a 263 population based clinical study of 86 patients

Diagnosis and treatment of cold 266 agglutinin mediated autoimmune hemolytic anemia

Primary cold agglutinin-associated lymphoproliferative 270 disease: a B-cell lymphoma of the bone marrow distinct

Autoimmune hemolytic anemia

Prevalence of venous

Rituximab: a review of its use in non-286

Hypogammaglobulinaemia after rituximab 294 treatment-incidence and outcomes